Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00618488 · ClinicalTrials.gov registry record · NA
Efficacy of Yogurt Containing BB12 in Subjects With GI Symptoms
A NA study, sponsored by University of North Carolina.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT00618488 is a NA study that has completed, run by University of North Carolina. The registered enrollment target is 63 participants.
The verdict
NCT00618488, a NA study, has completed, sponsored by University of North Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if probiotics bacteria, specifically bifidobacterium lactis (BB12) improve gastrointestinal symptoms in subjects with functional gastrointestinal symptoms (i.e., non-patients IBS/functional bowel disorders).
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Probiotic BB12 - Bifidobacterium lactis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2007-02 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00618488
The ClinicalTrials.gov registry entry for NCT00618488 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00618488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00618488 about?
NCT00618488 is a clinical study titled "Efficacy of Yogurt Containing BB12 in Subjects With GI Symptoms". The purpose of this study is to determine if probiotics bacteria, specifically bifidobacterium lactis (BB12) improve gastrointestinal symptoms in subjects with functional gastrointestinal symptoms (i.e., non-patients IBS/functional bowel disorders).
What is the current status of trial NCT00618488?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2007-02. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00618488?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic BB12 - Bifidobacterium lactis (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00618488?
This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.